Cannabinoids: Novel Medicines for the Treatment of Huntington's Disease

Publisher： Bentham Science Publishers

E-ISSN： 2212-3954|7|1|41-48

ISSN： 1574-8898

Source： Recent Patents on CNS Drug Discovery, Vol.7, Iss.1, 2012-04, pp. : 41-48

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pridopidine in the pharmacological treatment of Huntington’s disease

By Michl Martin   Schnopfhagen Katharina   Bonelli Raphael M  

Clinical Investigation, Vol. 3, Iss. 7, 2013-07 ,pp. : 691-699

Future Science

Access to resources Recommend Favorite

Lithium Treatment in Patients With Huntington's Disease and Suicidal Behavior

By  

MOVEMENT DISORDERS, Vol. 30, Iss. 10, 2015-09 ,pp. : 1438-1438

John Wiley & Sons Inc

Access to resources Recommend Favorite

Potential trade‐offs in treatment of premanifest Huntington's disease

By  

MOVEMENT DISORDERS, Vol. 30, Iss. 10, 2015-09 ,pp. : 1319-1323

John Wiley & Sons Inc

Access to resources Recommend Favorite

A randomized, placebo‐controlled trial of AFQ056 for the treatment of chorea in Huntington's disease

By  

MOVEMENT DISORDERS, Vol. 30, Iss. 3, 2015-03 ,pp. : 427-431

John Wiley & Sons Inc

Access to resources Recommend Favorite

Ethyl‐eicosapentaenoic acid treatment in Huntington's disease: A placebo‐controlled clinical trial

By  

MOVEMENT DISORDERS, Vol. 30, Iss. 10, 2015-09 ,pp. : 1426-1429

John Wiley & Sons Inc

Access to resources Recommend Favorite